This website sets cookies which are used to offer a personalized experience on our website, generate statistics, and realize advertising or social network tracking. Find out more about our Privacy & Cookie policy and how to manage them on your browser. You can change your cookie settings at any time.


Dear Colleagues,

It is our pleasure to personally invite you to join us at one of the most established global liver meetings; the 16th International Symposium on Viral Hepatitis and Liver Disease (ISVHLD). Over the 45-year legacy of the ISVHLD Meeting, much has changed, and so must the meeting. With renewed vigor and an exciting new focus, the ISVHLD Meeting will be delivered as the 16th ISVHLD Global Hepatitis Summit, in Toronto Canada June 14th – 17th, 2018.

As is the tradition of the ISVHLD, the Global Hepatitis Summit will bring together top clinicians and researchers from around the world. In addition to delivering the highest quality scientific program, the upcoming summit will add a new dimension; an important focus on global public health. With the remarkable therapeutic developments in recent years, the prospect of disease elimination has emerged with the full backing of the WHO, the CDC, and other leading global and national public health bodies.

To highlight the importance of these efforts, the Global Hepatitis Summit will include plenary and parallel public health sessions to complement the high quality basic and clinical scientific presentations typical of the ISVHLD. In addition, the Global Hepatitis Summit will feature a Global Village presented in partnership with the World Hepatitis Alliance, an advocacy focused organization committed to achieving a world free from viral hepatitis. This live hub will bring together community organizations, governmental groups and patients to help drive the public health and awareness agenda.

The Summit will be focused on hepatitis and other non-viral liver diseases and will feature:

    • 4-day ISVHLD meeting refreshed and rebranded, attracting 2,000+ global professionals organized in collaboration with the world-leading liver disease associations.
    • 100+ internationally recognized speakers, leading plenary and parallel scientific sessions in basic, clinical, and public health science of viral hepatitis and liver disease
    • Ground breaking abstracts, scientific posters, and e-poster presentations
    • A Global Village showcasing the advocacy work of community organizations, non-government, and governmental groups
    • Industry inclusive social events, receptions, and faculty events
    • State of the art interactive exhibits
    • Exclusive industry symposia sessions

We have assembled an outstanding Scientific Program Committee of world leaders to develop the highest quality scientific program. In attending the summit, you will contribute to driving the next phase of the international agenda on the diagnosis and treatment of viral hepatitis and liver disease.

The 16th ISVHLD Global Hepatitis Summit promises to be a recharged meeting not to be missed!

We look forward to seeing you in Toronto!

Harry L. A. Janssen

MD, PhD.
Francis Family Chair in Liver
Research, Director Toronto
Centre for Liver Disease,
Professor of Medicine,
University of Toronto

Jordan J. Feld

Research Director Toronto
Centre for Liver Disease,
Scientist, Sandra Rotman
Centre for Global Health
University Health Network

Adam J. Gehring

Biology Lead, Toronto
Centre for Liver Disease,
UHN Scientist & Programme
Lead, Infection and Immunity,
Toronto General Hospital
Research Institute